Larvol Delta - Confo-Therapeutics-Awarded-EUR-1M-VLAIO-Grant-for-PreClinical-Development-of-CFTX1554-an-AT2R-Modulator-for-the-Treatment-of-Neuropathic-Pain

CFTX-1554 - Confo Therap

https://www.businesswire.com/news/home/20210330005069/en/Confo-Therapeutics-Awarded-EUR-1M-VLAIO-Grant-for-Pre-Clinical-Development-of-CFTX-1554-an-AT2R-Modulator-for-the-Treatment-of-Neuropathic-Pain

Mar 30, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev